Opportunities exist to educate and engage patients
Patients with T2D are 2 times more likely to die from CV disease.1
99% of patients with T2D and CV disease say that if they knew they were at increased risk for CV events, they would have done something about it.2
Care transitions can cause care delivery breakdown for high-risk comorbid patients with T2D and CV disease.3
Approximately 50% of patients with T2D are nonadherent or discontinue treatment.4
Only 20% of Black and Latina women know that heart disease is the number 1 killer in women.5